BeStock  
Markets › Compare › NRIX vs DMRA

NRIX vs DMRA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NRIX · Nurix Therapeutics$12.85 ▼ 5.51%
DMRA · Damora Therapeutics$23.22 ▼ 4.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

67104142180217Nov 24, '25May 26, '26Nov 20, '26
  • NRIX -25.1%
  • DMRA +42.4%

Head to head

MetricNRIXDMRA
Price$12.85$23.22
Change today▼ 5.51%▼ 4.44%
Market cap$1.40B$1.44B
Return, 3 months-51.1%-23.4%
Return, year to date-32.3%+0.9%
Return, 1 year-23.3%+38.5%
P/E (TTM)5.313.6
P/B1.43.9
P/E percentile vs own 5y98th99th
Dividend yield––
Revenue growth (YoY, latest qtr)+8,426.3%–
Net profit growth (YoY)+736.2%-921.1%
Gross margin––
Operating margin41.3%–
Net margin42.0%–
Return on equity44.0%-156.6%
Analyst target vs. price+174.9%+101.0%
Analyst buy share100%100%
RSI (14)2154
30-day volatility149.6%61.9%
Max drawdown, 1 year-53.8%-46.9%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DMRA is the largest of the group by market value.
  • DMRA has returned the most over the past year.
  • NRIX carries the lowest trailing P/E.
  • DMRA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top